EXPRES2ION BIOTECHNOLOGIES APS has a total of 13 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are INST FRANCAIS D IMMUNOLOGIE, REFUGE BIOTECHNOLOGIES INC and ANHUI SINOBIOWAY CELL THERAPY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Fermentation | |
#6 | Enzymes | |
#7 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | De Jongh Willem Adriaan | 10 |
#2 | Dyring Charlotte | 7 |
#3 | Lykkegaard Helene | 6 |
#4 | Rasmussen Peter Birk | 6 |
#5 | Søgaard Teit | 3 |
#6 | De Jongh Willem | 3 |
#7 | Søgaard Teit Max Moscote | 2 |
#8 | Clemmensen Stine | 2 |
#9 | Jørgensen Thomas Dan | 2 |
#10 | Cowman Alan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020144358A1 | Glyco-engineered immunization antigens | |
WO2020144359A1 | Production of protein with humanized n-glycosylation in insect cells | |
US2019358313A1 | New flavivirus vaccine | |
WO2013174889A1 | Novel drosophila s2 cell line | |
AU2009256566A1 | Improved protein expression system |